William Blair Decreases Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – William Blair reduced their Q1 2025 earnings per share estimates for Henry Schein in a research note issued on Tuesday, March 11th. William Blair analyst B. Vazquez now expects that the company will post earnings of $1.10 per share for the quarter, down from their prior forecast of $1.16. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. William Blair also issued estimates for Henry Schein’s Q2 2025 earnings at $1.17 EPS, Q3 2025 earnings at $1.35 EPS, Q4 2025 earnings at $1.25 EPS, FY2025 earnings at $4.87 EPS, Q1 2026 earnings at $1.17 EPS, Q2 2026 earnings at $1.23 EPS, Q4 2026 earnings at $1.35 EPS and FY2026 earnings at $5.17 EPS.

HSIC has been the subject of several other reports. UBS Group reduced their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Jefferies Financial Group upped their target price on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and upped their target price for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Wells Fargo & Company started coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target for the company. Finally, Barrington Research reiterated an “outperform” rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Trading Down 0.2 %

Shares of HSIC stock opened at $69.81 on Thursday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a market cap of $8.67 billion, a price-to-earnings ratio of 28.73, a PEG ratio of 2.13 and a beta of 0.90. The stock has a 50 day simple moving average of $74.78 and a 200-day simple moving average of $72.62. Henry Schein has a 1-year low of $63.67 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same period in the previous year, the firm posted $0.66 earnings per share. The company’s revenue was up 5.8% compared to the same quarter last year.

Hedge Funds Weigh In On Henry Schein

Several large investors have recently modified their holdings of HSIC. Palestra Capital Management LLC acquired a new position in shares of Henry Schein in the 4th quarter valued at $182,988,000. Lyrical Asset Management LP acquired a new position in shares of Henry Schein in the 4th quarter valued at $126,655,000. Norges Bank acquired a new position in shares of Henry Schein in the 4th quarter valued at $103,301,000. Steadfast Capital Management LP lifted its stake in shares of Henry Schein by 254.2% in the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company’s stock valued at $113,336,000 after purchasing an additional 1,175,408 shares during the last quarter. Finally, ING Groep NV acquired a new position in shares of Henry Schein in the 3rd quarter valued at $63,226,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.